About the Special Issue

Cancer is a significant disease that seriously affects human health and remains one of the most challenging diseases worldwide. With the growth of human life and the development of detection technology, the number of cancer patients has increased yearly. In recent decades, cancer therapy has become more personalized, efforts have been made toward drug development and novel therapeutic methods.  Discovery and identification of novel molecules involved in cancer progression allow for a complete understanding of the biology behind cancer, and corresponding therapies against these molecular targets can provide more options for cancer treatment. Many molecular-targeted therapies are being tested in pre-clinical and clinical studies.
Given the complexity of this topic and its impact on clinical practice and public health, ETAT is launching a Special Issue entitled “Molecular Targeted Therapy for Cancer” to provide a platform for active discussion and summarizing current knowledge of new perspectives on developing novel molecular targeted therapeutic approaches and biomarkers for cancer. We welcome high-quality original research articles, brief reports, as well as opinion, hypothesis, and review articles, and especially encourage submissions from early-career scientists.

Call for Papers